Literature DB >> 5486859

Experiences with F-32 in advanced carcinoma of the prostate.

S H Corwin, M Malament, M Small, H D Strauss.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1970        PMID： 5486859     DOI： 10.1016/s0022-5347(17)61826-3

Source DB:  PubMed          Journal:  J Urol        ISSN： 0022-5347            Impact factor:   7.450


× No keyword cloud information.
  3 in total

1.  Androgen priming and cytotoxic chemotherapy in advanced prostatic cancer.

Authors:  A J Suarez; D L Lamm; H M Radwin; M Sarosdy; G Clark; C K Osborne
Journal:  Cancer Chemother Pharmacol       Date:  1982       Impact factor: 3.333

2.  Recurrent urethritis in women.

Authors:  A W Bruce; P Chadwick; A Hassan; G F VanCott
Journal:  Can Med Assoc J       Date:  1973-04-21       Impact factor: 8.262

3.  Synthetic androgens suppress the transformed phenotype in the human prostate carcinoma cell line LNCaP.

Authors:  D A Wolf; P Schulz; F Fittler
Journal:  Br J Cancer       Date:  1991-07       Impact factor: 7.640
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.